2(3H)-benzoxazolone and bioisosters as "privileged scaffold" in the design of pharmacological probes

Curr Med Chem. 2005;12(7):877-85. doi: 10.2174/0929867053507388.

Abstract

The 2(3H)-benzoxazolone heterocycle and its bioisosteric surrogates (such as 2(3H)-benzothiazolinone, benzoxazinone, etc.) have received considerable attention from the medicinal chemists owing to their capacity to mimic a phenol or a catechol moiety in a metabolically stable template. These heterocycles and pyrocatechol have indeed similar pKa's, electronic charge distribution, and chemical reactivity. Therapeutic applications of this template are very broad, and range from analgesic anti-inflammatory compounds (including PPAR-gamma antagonists) to antipsychotic and neuroprotective anticonvulsant compounds. High affinity ligands have been obtained also for dopaminergic (D2 and D4), serotoninergic (5-HT1A and 5-HT-2A), sigma-1 and sigma-2 receptors. Owing to the high number of positive hits encountered with this heterocycle and its congeners, 2(3H)-benzoxazolone template certainly deserves the title of "privileged scaffold" in medicinal chemistry.

Publication types

  • Review

MeSH terms

  • Benzoxazoles / chemistry*
  • Benzoxazoles / pharmacology*
  • Benzoxazoles / therapeutic use
  • Humans
  • Ligands
  • Models, Molecular
  • Molecular Probes / chemistry
  • Molecular Probes / pharmacology
  • Molecular Probes / therapeutic use
  • Molecular Structure

Substances

  • Benzoxazoles
  • Ligands
  • Molecular Probes
  • benzoxazolone